Sparsentan Recruiting Phase 2 Trials for Immunoglobulin A Nephropathy / Glomerulonephritis / IgA Glomerulonephritis / Kidney Diseases / Immune System Diseases / Autoimmune Diseases Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04663204A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy